In this study we examined TH1 and TH17 immune responses to rat myelin basic protein (MBP), bovine MBP, human MBP, MBP 68-86, MBP 63-81 and ovalbumin in Lewis rats to determine which MBP antigen is recognized following ischemic brain injury. Responses were compared to animals immunized to rat MBP. Data show that immune responses following immunization with rat MBP are promiscuous with cross reaction to MBP from other species. After stroke, few animals develop TH1 or TH17 responses to MBP, but when those responses occur, especially TH1 responses to rat MBP in the brain, they are predictive of worse stroke outcome.
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TH1 type responses to myelin basic protein (MBP) after experimental stroke are associated with, and seem to mediate, worse functional outcome (Becker et al., 2005; Zierath et al., 2010b Zierath et al., , 2013 . The exact mechanisms by which TH1 immune responses to MBP worsen stroke outcome are unclear, but there is evidence of enhanced CD8 + infiltration and increased brain atrophy at one month after middle cerebral artery occlusion (MCAO) in animals with TH1(+) responses (Becker et al., 2005) . And while animals with TH1(+) responses to MBP perform worse on behavioral tests after stroke, they do not manifest overt signs of experimental allergic encephalomyelitis (EAE) (Becker et al., 2005; Gee et al., 2008 Gee et al., , 2009 Zierath et al., 2010b) . It is also true that the phenotype and pathology of EAE differ depending upon the antigen used to initiate EAE, the species from which the antigen is derived, the portion of antigen to which the immune response is directed, and the type of cells mediating the immune response (Domingues et al., 2010; Jager et al., 2009; Mannie et al., 2009; Stromnes et al., 2008) . Following stroke there is necrosis of brain tissue and antigens from dying cells are presented to the immune system, either within the brain or in the periphery (Becker et al., 2005; Planas et al., 2012; van Zwam et al., 2009) . Given the degree of necrosis that accompanies severe brain injury, these neural antigens have undoubtedly been transformed from their native state. It is thus unclear which antigens drive the post-ischemic immune response and whether the outcomes differ depending upon the target epitope. In prior studies we assessed the immune response to MBP after stroke using commercially available bovine MBP and human MBP and found that the immune responses to both of these heterologous proteins were predictive of functional outcome (Becker et al., 2005; Zierath et al., 2013) . In this study we aimed to determine whether the immune response to MBP after stroke was more robust to whole MBP or one its encephalitogenic peptides and whether there were differences in the responses to autologous rat MBP and heterologous (bovine, human) MBP. Further, the immune responses were assessed in the spleen, lymph node and brain to evaluate whether the responses differed based on the compartment (spleen, lymph node, brain) tested. Finally, we aimed to determine if the responses to a particular antigen were more predictive of outcome than responses to other antigens in animals subjected to stroke. As an immunologic control, a subset of animals was immunized to rat MBP and immune responses to the same set of antigens assessed.
Methods

Animals
Male Lewis rats (275-325 g) were purchased from Taconic Farms. All experiments were approved by the Institutional Animal Care and Use Committee (IACUC).
Immunization to MBP
Male Lewis rats were immunized with either recombinant rat MBP (prepared by NeoBioScience™) or OVA (Sigma). Antigens were mixed in complete Freund's adjuvant and injected into the hind foot pad. Two doses of MBP were used, 50 μg (n = 16) and 100 μg (N = 14). Control animals were immunized with OVA 50 μg (N = 18). Twelve days after immunization, animals were sacrificed and lymphocytes isolated from the brain, spleen, and cervical lymph nodes for ELISPOT assay.
